Press Releases :: Algernon Pharmaceuticals Inc. (AGN)

Mar 21, 2019 7:00am EDT

Algernon Pharmaceuticals Appoints Leading Liver Disease Expert Dr. Arun Sanyal to Its Medical and Scientific Advisory Board

Mar 12, 2019 11:46pm EDT

Algernon Retains Renmark Financial Communications

Feb 25, 2019 7:00am EST

Algernon Pharmaceuticals Expands Its Research Program to Include Idiopathic Pulmonary Fibrosis

Feb 19, 2019 7:00am EST

Algernon Pharmaceuticals Begins Trading on The CSE Under The Symbol AGN

arrow_back
1
…
9
10
11
12
13
14
15
16
17
18

rss_feed News RSS

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company.

Sign up for our News Releases and Updates

Head Office

Suite 400 - 601 West Broadway
Vancouver, British Columbia V5Z 4C2

Follow Us On

© Algernon Pharmaceuticals Inc. - All Rights Reserved